资讯
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...
1 天
News-Medical.Net on MSNStudy offers a potential new strategy to improve treatment responses in multiple myeloma ...Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...
1 天
News-Medical.Net on MSNMultiple myeloma care improved using innovative optical genome mappingResearchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...
Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...
A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...
A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...
Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...
A New York City federal court has dismissed a proposed class-action lawsuit against Bristol Myers Squibb that accused the ...
"The developers expect to create Russia's first drug for multiple myeloma based on CAR-NK therapy. It is planned that the drug using the new technology will pass all the necessary clinical trials and ...
A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...
The new time-saving test is intended for people with MGUS (Monoclonal Gammopathy of Unknown Significance), a precursor condition of myeloma.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果